A 0 1 0 1 O
prolonged 2 11 2 11 O
history 12 19 12 19 O
of 20 22 20 22 O
cigarette 23 32 23 32 O
smoking 33 40 33 40 O
( 41 42 41 42 O
greater 42 49 42 49 O
than 50 54 50 54 O
or 55 57 55 57 O
equal 58 63 58 63 O
to 64 66 64 66 O
20 67 69 67 69 B-lower_bound
pack 70 74 70 74 I-lower_bound
- 74 75 74 75 O
year 75 79 75 79 O
smoking 80 87 80 87 O
history 88 95 88 95 O
within 96 102 96 102 O
the 103 106 103 106 O
past 107 111 107 111 B-upper_bound
two 112 115 112 115 I-upper_bound
years 116 121 116 121 I-upper_bound
) 121 122 121 122 O

ANC 0 3 123 126 B-clinical_variable
> 4 5 127 128 O
1000 6 10 129 133 B-lower_bound
/ 10 11 133 134 I-lower_bound
mm3 11 14 134 137 I-lower_bound
without 15 22 138 145 O
the 23 26 146 149 O
support 27 34 150 157 O
of 35 37 158 160 O
filgrastim 38 48 161 171 B-treatment

Active 0 6 172 178 O
systemic 7 15 179 187 B-chronic_disease
infections 16 26 188 198 I-chronic_disease
requiring 27 36 199 208 O
anti 37 41 209 213 B-treatment
- 41 42 213 214 I-treatment
infective 42 51 214 223 I-treatment
treatment 52 61 224 233 I-treatment
, 61 62 233 234 O
coagulation 63 74 235 246 B-chronic_disease
disorders 75 84 247 256 I-chronic_disease
, 84 85 256 257 O
or 86 88 258 260 O
any 89 92 261 264 O
other 93 98 265 270 O
active 99 105 271 277 O
or 106 108 278 280 O
uncompensated 109 122 281 294 O
major 123 128 295 300 O
medical 129 136 301 308 B-chronic_disease
illnesses 137 146 309 318 I-chronic_disease

Age 0 3 319 322 B-age
greater 4 11 323 330 O
than 12 16 331 335 O
or 17 19 336 338 O
equal 20 25 339 344 O
to 26 28 345 347 O
18 29 31 348 350 B-lower_bound
years 32 37 351 356 I-lower_bound
and 38 41 357 360 O
less 42 46 361 365 O
than 47 51 366 370 O
or 52 54 371 373 O
equal 55 60 374 379 O
to 61 63 380 382 O
70 64 66 383 385 B-upper_bound
years 67 72 386 391 I-upper_bound

Age 0 3 392 395 B-age
greater 4 11 396 403 O
than 12 16 404 408 O
or 17 19 409 411 O
equal 20 25 412 417 O
to 26 28 418 420 O
65 29 31 421 423 B-lower_bound
years 32 37 424 429 I-lower_bound

Any 0 3 430 433 O
form 4 8 434 438 O
of 9 11 439 441 O
primary 12 19 442 449 B-chronic_disease
immunodeficiency 20 36 450 466 I-chronic_disease
( 37 38 467 468 O
such 38 42 468 472 O
as 43 45 473 475 O
Severe 46 52 476 482 B-chronic_disease
Combined 53 61 483 491 I-chronic_disease
Immunodeficiency 62 78 492 508 I-chronic_disease
Disease 79 86 509 516 I-chronic_disease
and 87 90 517 520 O
AIDS 91 95 521 525 B-chronic_disease
) 95 96 525 526 O

Clinical 0 8 527 535 O
performance 9 20 536 547 O
status 21 27 548 554 O
of 28 30 555 557 O
ECOG 31 35 558 562 B-clinical_variable
0 36 37 563 564 B-lower_bound
or 38 40 565 567 O
1 41 42 568 569 B-upper_bound

Concurrent 0 10 570 580 O
opportunistic 11 24 581 594 B-chronic_disease
infections 25 35 595 605 I-chronic_disease

Concurrent 0 10 606 616 B-treatment
systemic 11 19 617 625 I-treatment
steroid 20 27 626 633 I-treatment
therapy 28 35 634 641 I-treatment

Confirmation 0 12 642 654 O
of 13 15 655 657 O
diagnosis 16 25 658 667 O
of 26 28 668 670 O
metastatic 29 39 671 681 B-cancer
cancer 40 46 682 688 I-cancer
by 47 49 689 691 O
the 50 53 692 695 O
NCI 54 57 696 699 O
Laboratory 58 68 700 710 O
of 69 71 711 713 O
Pathology 72 81 714 723 O

Documented 0 10 724 734 O
Child 11 16 735 740 B-clinical_variable
- 16 17 740 741 I-clinical_variable
Pugh 17 21 741 745 I-clinical_variable
score 22 27 746 751 I-clinical_variable
of 28 30 752 754 O
B 31 32 755 756 O
or 33 35 757 759 O
C 36 37 760 761 O
for 38 41 762 765 O
hepatocellular 42 56 766 780 B-cancer
carcinoma 57 66 781 790 I-cancer
patients 67 75 791 799 O
with 76 80 800 804 O
known 81 86 805 810 O
underlying 87 97 811 821 O
liver 98 103 822 827 B-chronic_disease
dysfunction 104 115 828 839 I-chronic_disease

Documented 0 10 840 850 O
FEV1 11 15 851 855 B-clinical_variable
less 16 20 856 860 O
than 21 25 861 865 O
or 26 28 866 868 O
equal 29 34 869 874 O
to 35 37 875 877 O
60 38 40 878 880 B-upper_bound
% 40 41 880 881 I-upper_bound
predicted 42 51 882 891 O
tested 52 58 892 898 O
in 59 61 899 901 O
patients 62 70 902 910 O

Documented 0 10 911 921 O
LVEF 11 15 922 926 B-clinical_variable
less 16 20 927 931 O
than 21 25 932 936 O
or 26 28 937 939 O
equal 29 34 940 945 O
to 35 37 946 948 O
45 38 40 949 951 B-upper_bound
% 40 41 951 952 I-upper_bound
tested 42 48 953 959 O
in 49 51 960 962 O
patients 52 60 963 971 O

Grade 0 5 972 977 O
3 6 7 978 979 O
or 8 10 980 982 O
4 11 12 983 984 O
major 13 18 985 990 O
organ 19 24 991 996 O
irAEs 25 30 997 1002 O
following 31 40 1003 1012 O
treatment 41 50 1013 1022 B-treatment
with 51 55 1023 1027 I-treatment
anti 56 60 1028 1032 I-treatment
- 60 61 1032 1033 I-treatment
PD-1 61 65 1033 1037 I-treatment
/ 65 66 1037 1038 I-treatment
PD 66 68 1038 1040 I-treatment
- 68 69 1040 1041 I-treatment
L1 69 71 1041 1043 I-treatment

Hemoglobin 0 10 1044 1054 B-clinical_variable
> 11 12 1055 1056 O
8.0 13 16 1057 1060 B-lower_bound
g 17 18 1061 1062 I-lower_bound
/ 18 19 1062 1063 I-lower_bound
dL. 19 22 1063 1066 I-lower_bound
Subjects 23 31 1067 1075 O
may 32 35 1076 1079 O
be 36 38 1080 1082 O
transfused 39 49 1083 1093 O
to 50 52 1094 1096 O
reach 53 58 1097 1102 O
this 59 63 1103 1107 O
cut 64 67 1108 1111 O
- 67 68 1111 1112 O
off 68 71 1112 1115 O

History 0 7 1116 1123 O
of 8 10 1124 1126 O
coronary 11 19 1127 1135 B-treatment
revascularization 20 37 1136 1153 I-treatment
or 38 40 1154 1156 O
ischemic 41 49 1157 1165 B-chronic_disease
symptoms 50 58 1166 1174 I-chronic_disease

History 0 7 1175 1182 O
of 8 10 1183 1185 O
major 11 16 1186 1191 O
organ 17 22 1192 1197 O
autoimmune 23 33 1198 1208 B-chronic_disease
disease 34 41 1209 1216 I-chronic_disease

History 0 7 1217 1224 O
of 8 10 1225 1227 O
severe 11 17 1228 1234 O
immediate 18 27 1235 1244 O
hypersensitivity 28 44 1245 1261 O
reaction 45 53 1262 1270 O
to 54 56 1271 1273 O
cyclophosphamide 57 73 1274 1290 B-allergy_name
, 73 74 1290 1291 O
fludarabine 75 86 1292 1303 B-allergy_name
, 86 87 1303 1304 O
or 88 90 1305 1307 O
aldesleukin 91 102 1308 1319 B-allergy_name

Lesions 0 7 1320 1327 O
that 8 12 1328 1332 O
have 13 17 1333 1337 O
been 18 22 1338 1342 O
treated 23 30 1343 1350 O
with 31 35 1351 1355 O
stereotactic 36 48 1356 1368 B-treatment
radiosurgery 49 61 1369 1381 I-treatment
must 62 66 1382 1386 O
be 67 69 1387 1389 O
clinically 70 80 1390 1400 O
stable 81 87 1401 1407 O
for 88 91 1408 1411 O
one 92 95 1412 1415 B-upper_bound
month 96 101 1416 1421 I-upper_bound
after 102 107 1422 1427 O
treatment 108 117 1428 1437 B-treatment
for 118 121 1438 1441 O
the 122 125 1442 1445 O
patient 126 133 1446 1453 O
to 134 136 1454 1456 O
be 137 139 1457 1459 O
eligible 140 148 1460 1468 O

Measurable 0 10 1469 1479 O
( 11 12 1480 1481 O
per 12 15 1481 1484 O
RECIST 16 22 1485 1491 O
v1.0 23 27 1492 1496 O
criteria 28 36 1497 1505 O
) 36 37 1505 1506 O
, 37 38 1506 1507 O
metastatic 39 49 1508 1518 B-cancer
cancer 50 56 1519 1525 I-cancer
of 57 59 1526 1528 O
one 60 63 1529 1532 O
of 64 66 1533 1535 O
the 67 70 1536 1539 O
following 71 80 1540 1549 O
types 81 86 1550 1555 O
: 86 87 1555 1556 O
upper 88 93 1557 1562 B-cancer
or 94 96 1563 1565 O
lower 97 102 1566 1571 B-cancer
gastrointestinal 103 119 1572 1588 I-cancer
, 119 120 1588 1589 O
hepatobiliary 121 134 1590 1603 B-cancer
, 134 135 1603 1604 O
genitourinary 136 149 1605 1618 B-cancer
, 149 150 1618 1619 O
breast 151 157 1620 1626 B-cancer
, 157 158 1626 1627 O
ovarian 159 166 1628 1635 B-cancer
/ 166 167 1635 1636 I-cancer
endometrial 167 178 1636 1647 I-cancer
, 178 179 1647 1648 O
or 180 182 1649 1651 O
glioblastoma 183 195 1652 1664 B-cancer

More 0 4 1665 1669 O
than 5 9 1670 1674 O
four 10 14 1675 1679 B-lower_bound
weeks 15 20 1680 1685 I-lower_bound
must 21 25 1686 1690 O
have 26 30 1691 1695 O
elapsed 31 38 1696 1703 O
since 39 44 1704 1709 O
any 45 48 1710 1713 O
prior 49 54 1714 1719 B-treatment
systemic 55 63 1720 1728 I-treatment
therapy 64 71 1729 1736 I-treatment
at 72 74 1737 1739 O
the 75 78 1740 1743 O
time 79 83 1744 1748 O
the 84 87 1749 1752 O
patient 88 95 1753 1760 O
receives 96 104 1761 1769 O
the 105 108 1770 1773 O
preparative 109 120 1774 1785 O
regimen 121 128 1786 1793 O
, 128 129 1793 1794 O
and 130 133 1795 1798 O
patients 134 142 1799 1807 O
toxicities 143 153 1808 1818 O
must 154 158 1819 1823 O
have 159 163 1824 1828 O
recovered 164 173 1829 1838 O
to 174 176 1839 1841 O
a 177 178 1842 1843 O
grade 179 184 1844 1849 B-lower_bound
1 185 186 1850 1851 I-lower_bound
or 187 189 1852 1854 O
less 190 194 1855 1859 O

Patients 0 8 1860 1868 O
of 9 11 1869 1871 O
both 12 16 1872 1876 O
genders 17 24 1877 1884 O
must 25 29 1885 1889 O
be 30 32 1890 1892 O
willing 33 40 1893 1900 B-contraception_consent
to 41 43 1901 1903 I-contraception_consent
practice 44 52 1904 1912 I-contraception_consent
birth 53 58 1913 1918 I-contraception_consent
control 59 66 1919 1926 I-contraception_consent
from 67 71 1927 1931 O
the 72 75 1932 1935 O
time 76 80 1936 1940 O
of 81 83 1941 1943 O
enrollment 84 94 1944 1954 O
on 95 97 1955 1957 O
this 98 102 1958 1962 O
study 103 108 1963 1968 O
and 109 112 1969 1972 O
for 113 116 1973 1976 O
four 117 121 1977 1981 B-upper_bound
months 122 128 1982 1988 I-upper_bound
after 129 134 1989 1994 O
treatment 135 144 1995 2004 B-treatment

Patients 0 8 2005 2013 O
who 9 12 2014 2017 O
are 13 16 2018 2021 O
receiving 17 26 2022 2031 O
any 27 30 2032 2035 O
other 31 36 2036 2041 O
investigational 37 52 2042 2057 B-treatment
agents 53 59 2058 2064 I-treatment

Patients 0 8 2065 2073 O
with 9 13 2074 2078 O
3 14 15 2079 2080 B-upper_bound
or 16 18 2081 2083 O
fewer 19 24 2084 2089 O
brain 25 30 2090 2095 B-cancer
metastases 31 41 2096 2106 I-cancer
that 42 46 2107 2111 O
are 47 50 2112 2115 O
less 51 55 2116 2120 O
than 56 60 2121 2125 O
or 61 63 2126 2128 O
equal 64 69 2129 2134 O
to 70 72 2135 2137 O
1 73 74 2138 2139 B-upper_bound
cm 75 77 2140 2142 I-upper_bound
in 78 80 2143 2145 I-upper_bound
diameter 81 89 2146 2154 I-upper_bound
and 90 93 2155 2158 O
asymptomatic 94 106 2159 2171 B-cancer
are 107 110 2172 2175 O
eligible 111 119 2176 2184 O

Patients 0 8 2185 2193 O
with 9 13 2194 2198 O
Hepatocellular 14 28 2199 2213 B-cancer
carcinoma 29 38 2214 2223 I-cancer
patients 39 47 2224 2232 O
must 48 52 2233 2237 O
have 53 57 2238 2242 O
received 58 66 2243 2251 O
sorafenib 67 76 2252 2261 B-treatment
( 77 78 2262 2263 I-treatment
Nexavar 78 85 2263 2270 I-treatment
) 86 87 2271 2272 I-treatment
, 87 88 2272 2273 O
since 89 94 2274 2279 O
level 95 100 2280 2285 O
1 101 102 2286 2287 O
data 103 107 2288 2292 O
support 108 115 2293 2300 O
a 116 117 2301 2302 O
survival 118 126 2303 2311 O
benefit 127 134 2312 2319 O
with 135 139 2320 2324 O
this 140 144 2325 2329 O
agent 145 150 2330 2335 O

Patients 0 8 2336 2344 O
with 9 13 2345 2349 O
glioblastoma 14 26 2350 2362 B-cancer
must 27 31 2363 2367 O
have 32 36 2368 2372 O
received 37 45 2373 2381 O
standard 46 54 2382 2390 O
surgery 55 62 2391 2398 B-treatment
, 62 63 2398 2399 O
radiation 64 73 2400 2409 B-treatment
therapy 74 81 2410 2417 I-treatment
, 81 82 2417 2418 O
and 83 86 2419 2422 O
chemotherapy 87 99 2423 2435 B-treatment
for 100 103 2436 2439 O
their 104 109 2440 2445 O
primary 110 117 2446 2453 B-cancer
tumors 118 124 2454 2460 I-cancer
and 125 128 2461 2464 O
require 129 136 2465 2472 O
resection 137 146 2473 2482 B-treatment
of 147 149 2483 2485 O
their 150 155 2486 2491 O
tumors 156 162 2492 2498 O
for 163 166 2499 2502 O
palliative 167 177 2503 2513 O
or 178 180 2514 2516 O
other 181 186 2517 2522 O
clinical 187 195 2523 2531 O
indication 196 206 2532 2542 O

Patients 0 8 2543 2551 O
with 9 13 2552 2556 O
metastatic 14 24 2557 2567 B-cancer
colorectal 25 35 2568 2578 I-cancer
cancer 36 42 2579 2585 I-cancer
must 43 47 2586 2590 O
have 48 52 2591 2595 O
received 53 61 2596 2604 O
oxaliplatin 62 73 2605 2616 B-treatment
or 74 76 2617 2619 O
irinotecan 77 87 2620 2630 B-treatment

Platelet 0 8 2631 2639 B-clinical_variable
count 9 14 2640 2645 I-clinical_variable
greater 15 22 2646 2653 O
than 23 27 2654 2658 O
or 28 30 2659 2661 O
equal 31 36 2662 2667 O
to 37 39 2668 2670 O
100,000 40 47 2671 2678 B-lower_bound
/ 47 48 2678 2679 I-lower_bound
mm3 48 51 2679 2682 I-lower_bound

Refractory 0 10 2683 2693 O
to 11 13 2694 2696 O
approved 14 22 2697 2705 O
standard 23 31 2706 2714 B-treatment
systemic 32 40 2715 2723 I-treatment
therapy 41 48 2724 2731 I-treatment

Seronegative 0 12 2732 2744 O
for 13 16 2745 2748 O
HIV 17 20 2749 2752 B-chronic_disease
antibody 21 29 2753 2761 O

Seronegative 0 12 2762 2774 O
for 13 16 2775 2778 O
hepatitis 17 26 2779 2788 B-chronic_disease
B 27 28 2789 2790 I-chronic_disease
antigen 29 36 2791 2798 O
, 36 37 2798 2799 O
and 38 41 2800 2803 O
seronegative 42 54 2804 2816 O
for 55 58 2817 2820 O
hepatitis 59 68 2821 2830 B-chronic_disease
C 69 70 2831 2832 I-chronic_disease
antibody 71 79 2833 2841 O

Serum 0 5 2842 2847 O
ALT 6 9 2848 2851 B-clinical_variable
/ 9 10 2851 2852 O
AST 10 13 2852 2855 B-clinical_variable
less 14 18 2856 2860 O
than 19 23 2861 2865 O
or 24 26 2866 2868 O
equal 27 32 2869 2874 O
to 33 35 2875 2877 O
5.0 36 39 2878 2881 B-upper_bound
x 40 41 2882 2883 I-upper_bound
ULN 42 45 2884 2887 I-upper_bound

Serum 0 5 2888 2893 B-clinical_variable
creatinine 6 16 2894 2904 I-clinical_variable
less 17 21 2905 2909 O
than 22 26 2910 2914 O
or 27 29 2915 2917 O
equal 30 35 2918 2923 O
to 36 38 2924 2926 O
1.6 39 42 2927 2930 B-upper_bound
mg 43 45 2931 2933 I-upper_bound
/ 45 46 2933 2934 I-upper_bound
dL 46 48 2934 2936 I-upper_bound

Symptoms 0 8 2937 2945 O
of 9 11 2946 2948 O
respiratory 12 23 2949 2960 B-chronic_disease
dysfunction 24 35 2961 2972 I-chronic_disease

The 0 3 2973 2976 O
experimental 4 16 2977 2989 O
treatment 17 26 2990 2999 B-treatment
being 27 32 3000 3005 O
evaluated 33 42 3006 3015 O
in 43 45 3016 3018 O
this 46 50 3019 3023 O
protocol 51 59 3024 3032 O
depends 60 67 3033 3040 O
on 68 70 3041 3043 O
an 71 73 3044 3046 O
intact 74 80 3047 3053 O
immune 81 87 3054 3060 O
system 88 94 3061 3067 O

The 0 3 3068 3071 O
experimental 4 16 3072 3084 O
treatment 17 26 3085 3094 B-treatment
being 27 32 3095 3100 O
evaluated 33 42 3101 3110 O
in 43 45 3111 3113 O
this 46 50 3114 3118 O
protocol 51 59 3119 3127 O
depends 60 67 3128 3135 O
on 68 70 3136 3138 O
an 71 73 3139 3141 O
intact 74 80 3142 3148 O
immune 81 87 3149 3155 O
system 88 94 3156 3162 O
. 94 95 3162 3163 O
Patients 96 104 3164 3172 O
who 105 108 3173 3176 O
are 109 112 3177 3180 O
HIV 113 116 3181 3184 B-chronic_disease
seropositive 117 129 3185 3197 O
may 130 133 3198 3201 O
have 134 138 3202 3206 O
decreased 139 148 3207 3216 O
immune 149 155 3217 3223 O
- 155 156 3223 3224 O
competence 156 166 3224 3234 O
and 167 170 3235 3238 O
thus 171 175 3239 3243 O
may 176 179 3244 3247 O
be 180 182 3248 3250 O
less 183 187 3251 3255 O
responsive 188 198 3256 3266 O
to 199 201 3267 3269 O
the 202 205 3270 3273 O
experimental 206 218 3274 3286 O
treatment 219 228 3287 3296 O
and 229 232 3297 3300 O
more 233 237 3301 3305 O
susceptible 238 249 3306 3317 O
to 250 252 3318 3320 O
its 253 256 3321 3324 O
toxicities 257 267 3325 3335 O

These 0 5 3336 3341 O
patients 6 14 3342 3350 O
will 15 19 3351 3355 O
not 20 23 3356 3359 O
undergo 24 31 3360 3367 O
surgery 32 39 3368 3375 B-treatment
solely 40 46 3376 3382 O
for 47 50 3383 3386 O
treatment 51 60 3387 3396 B-treatment
on 61 63 3397 3399 O
this 64 68 3400 3404 O
protocol 69 77 3405 3413 O

Total 0 5 3414 3419 B-clinical_variable
bilirubin 6 15 3420 3429 I-clinical_variable
less 16 20 3430 3434 O
than 21 25 3435 3439 O
or 26 28 3440 3442 O
equal 29 34 3443 3448 O
to 35 37 3449 3451 O
2.0 38 41 3452 3455 B-upper_bound
mg 42 44 3456 3458 I-upper_bound
/ 44 45 3458 3459 I-upper_bound
dL 45 47 3459 3461 I-upper_bound
, 47 48 3461 3462 O
except 49 55 3463 3469 O
in 56 58 3470 3472 O
patients 59 67 3473 3481 O
with 68 72 3482 3486 O
Gilbert 73 80 3487 3494 B-chronic_disease
s 81 82 3495 3496 I-chronic_disease
Syndrome 83 91 3497 3505 I-chronic_disease
, 91 92 3505 3506 O
who 93 96 3507 3510 O
must 97 101 3511 3515 O
have 102 106 3516 3520 O
a 107 108 3521 3522 O
total 109 114 3523 3528 B-clinical_variable
bilirubin 115 124 3529 3538 I-clinical_variable
< 125 126 3539 3540 O
3.0 127 130 3541 3544 B-upper_bound
mg 131 133 3545 3547 I-upper_bound
/ 133 134 3547 3548 I-upper_bound
dL 134 136 3548 3550 I-upper_bound

WBC 0 3 3551 3554 B-clinical_variable
greater 4 11 3555 3562 O
than 12 16 3563 3567 O
or 17 19 3568 3570 O
equal 20 25 3571 3576 O
to 26 28 3577 3579 O
3000 29 33 3580 3584 B-upper_bound
/ 33 34 3584 3585 I-upper_bound
mm3 34 37 3585 3588 I-upper_bound

With 0 4 3589 3593 O
clinically 5 15 3594 3604 O
significant 16 27 3605 3616 O
atrial 28 34 3617 3623 B-chronic_disease
and/or 35 41 3624 3630 O
ventricular 42 53 3631 3642 B-chronic_disease
arrhythmias 54 65 3643 3654 I-chronic_disease
, 65 66 3654 3655 O
including 67 76 3656 3665 O
but 77 80 3666 3669 O
not 81 84 3670 3673 O
imited 85 91 3674 3680 O
to 92 94 3681 3683 O
: 94 95 3683 3684 O
atrial 96 102 3685 3691 B-chronic_disease
fibrillation 103 115 3692 3704 I-chronic_disease
, 115 116 3704 3705 O
ventricular 117 128 3706 3717 B-chronic_disease
tachycardia 129 140 3718 3729 I-chronic_disease
, 140 141 3729 3730 O
second- 142 149 3731 3738 O
or 150 152 3739 3741 O
third 153 158 3742 3747 B-chronic_disease
- 158 159 3747 3748 I-chronic_disease
degree 159 165 3748 3754 I-chronic_disease
heart 166 171 3755 3760 I-chronic_disease
block 172 177 3761 3766 I-chronic_disease
, 177 178 3766 3767 O
or 179 181 3768 3770 O
have 182 186 3771 3775 O
a 187 188 3776 3777 O
history 189 196 3778 3785 O
of 197 199 3786 3788 O
ischemic 200 208 3789 3797 B-chronic_disease
heart 209 214 3798 3803 I-chronic_disease
disease 215 222 3804 3811 I-chronic_disease
and/or 223 229 3812 3818 O
chest 230 235 3819 3824 O
pain 236 240 3825 3829 O

Women 0 5 3830 3835 B-gender
of 6 8 3836 3838 O
child 9 14 3839 3844 O
- 14 15 3844 3845 O
bearing 15 22 3845 3852 O
potential 23 32 3853 3862 O
must 33 37 3863 3867 O
have 38 42 3868 3872 O
a 43 44 3873 3874 O
negative 45 53 3875 3883 B-pregnancy
pregnancy 54 63 3884 3893 I-pregnancy
test 64 68 3894 3898 O
because 69 76 3899 3906 O
of 77 79 3907 3909 O
the 80 83 3910 3913 O
potentially 84 95 3914 3925 O
dangerous 96 105 3926 3935 O
effects 106 113 3936 3943 O
of 114 116 3944 3946 O
the 117 120 3947 3950 O
treatment 121 130 3951 3960 B-treatment
on 131 133 3961 3963 O
the 134 137 3964 3967 O
fetus 138 143 3968 3973 O

Women 0 5 3974 3979 B-gender
of 6 8 3980 3982 O
child 9 14 3983 3988 O
- 14 15 3988 3989 O
bearing 15 22 3989 3996 O
potential 23 32 3997 4006 O
who 33 36 4007 4010 O
are 37 40 4011 4014 B-pregnancy
pregnant 41 49 4015 4023 I-pregnancy
or 50 52 4024 4026 O
breastfeeding 53 66 4027 4040 O
because 67 74 4041 4048 O
of 75 77 4049 4051 O
the 78 81 4052 4055 O
potentially 82 93 4056 4067 O
dangerous 94 103 4068 4077 O
effects 104 111 4078 4085 O
of 112 114 4086 4088 O
the 115 118 4089 4092 O
treatment 119 128 4093 4102 B-treatment
on 129 131 4103 4105 O
the 132 135 4106 4109 O
fetus 136 141 4110 4115 O
or 142 144 4116 4118 O
infant 145 151 4119 4125 O

patients 0 8 4126 4134 O
with 9 13 4135 4139 O
recurrent 14 23 4140 4149 O
glioblastoma 24 36 4150 4162 B-cancer
who 37 40 4163 4166 O
require 41 48 4167 4174 O
steroids 49 57 4175 4183 B-treatment
for 58 61 4184 4187 O
clinical 62 70 4188 4196 O
indications 71 82 4197 4208 O

